NPPB and hydrops fetalis: The rationale behind using NPs as a therapeutic target in HF therapy [45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62] resides in the seemingly abnormal BNP processing with a subsequent deficiency in active forms and resistance to their biological effects in these patients [5].